The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Recombinant human nerve growth factor in the treatment of diabetic polyneuropathy
Abstract
To the Editor: The article by Apfel et al. concerning recombinant human nerve growth factor (rhNGF) in the treatment of diabetic polyneuropathy (DPN) highlights the dilemma facing many clinical trials dealing with degenerative neurologic disease.1 Although rhNGF may have some beneficial therapeutic effect in DPN, rhNGF has little chance of gaining sustained widespread clinical acceptance if the beneficial effect can only be demonstrated by various combinations of multiple endpoints that are individually, not statistically or clinically, significant. Patients and treating physicians need to “see” the benefit. Indeed, the clinical utility of some of the endpoints are vague. For example, one endpoint in this rhNGF clinical trial was the Neuropathy Impairment Lower Limbs (NISLL) score.1 The NISLL score is compiled from the grading of strength, sensation, and reflexes; the obtained score is then “normalized, in the mind of the examiner, for site, age, gender, height, weight, and physical fitness.”2 What does a NISLL score obtained in such a manner from the “mind of the examiner” actually signify? As the authors …
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Schulz (1995) · doi:10.1001/jama.1995.03520290060030 · Cited by 5,634
Assessment [RETIRED]: Magnetoencephalography (MEG)
(1992) · Neurology · doi:10.1212/wnl.42.1.1 · Cited by 232
Cited by
Boulton, A. J. M., Malik, R. A., Arezzo, J. C., & Sosenko, J. M. (2004) · Diabetes Care · doi:10.2337/diacare.27.6.1458 · Cited by 913
Potential therapeutic uses of BDNF in neurological and psychiatric disorders
Nagahara, A. H., & Tuszynski, M. H. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3366 · Cited by 867
Diabetic neuropathy: cellular mechanisms as therapeutic targets
Vincent, A. M., Callaghan, B. C., Smith, A. L., & Feldman, E. L. (2011) · Nature Reviews Neurology · doi:10.1038/nrneurol.2011.137 · Cited by 566
Neurological complications of HIV infection
McArthur, J. C., Brew, B. J., & Nath, A. (2005) · The Lancet Neurology · doi:10.1016/s1474-4422(05)70165-4 · Cited by 554
Vinik, A. I., Park, T. S., Stansberry, K. B., & Pittenger, G. L. (2000) · Diabetologia · doi:10.1007/s001250051477 · Cited by 489
Metadata
- Authors
- Riggs, J. E., Apfel, S. C., Litchy, W. J., Kessler, J. A., Sanders, C., Adornato, B. T., & Rask, C. A.
- Venue
- Neurology
- Published
- 1999-04-01
- Volume
- 52
- Issue
- 7
- Pages
- 1517-1517
- ISSN
- 0028-3878 (ISSN-L)
- 1526-632X
- OpenAlex
- W2065662892
- Cited by
- 182
- References
- 2
- FWCI
- 11.79
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Recombinant human nerve growth factor in the treatment of diabetic polyneuropathy. https://app.cochat.ai/papers/10.1212/wnl.52.7.1517-a
- The paper
- Riggs, J. E., Apfel, S. C., Litchy, W. J., Kessler, J. A., Sanders, C., Adornato, B. T., & Rask, C. A. (1999). Recombinant human nerve growth factor in the treatment of diabetic polyneuropathy. Neurology. https://doi.org/10.1212/wnl.52.7.1517-a
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.